Sign In
Get Clay Free →

Suggestions

    Yaniv Erlich

    CEO of Eleven Therapeutics/A recovering Ivy league Professor. #Hiring

    Professional Background

    Prof. Yaniv Erlich is an accomplished leader in the field of genomics and computational human genetics, currently serving as the Chief Executive Officer of Eleven Therapeutics. With a rich history of impactful roles in academia and industry, Dr. Erlich has established himself as a prominent figure in scientific research and innovation. Before stepping into his role at Eleven Therapeutics, he was the Chief Scientific Officer at MyHeritage, where he contributed significantly to advancements in genetic understanding for personal ancestry and health insights.

    Before transitioning to the biotechnology and genomics industries, Dr. Erlich had a notable career in academia. He was an Associate Professor of Computer Science at Columbia University, where he specialized in the intersection of computational methods and biological data. His tenure at Columbia included significant contributions to the field of bioinformatics, focusing on the analysis and interpretation of complex genetic information. Additionally, he held a Principal Investigator position at the Whitehead Institute at MIT, a leading research center in biological and genomic studies.

    Dr. Erlich’s deep involvement in both research and industry makes him a sought-after expert and advisor in the genomics domain. He has collaborated with multiple companies in the area of genomics and bioinformatics, providing valuable insights derived from his extensive knowledge and expertise.

    Education and Achievements

    Dr. Yaniv Erlich’s educational background lays a strong foundation for his impressive career. He graduated summa cum laude with a Bachelor's degree in Computational Neuroscience from Tel Aviv University in 2006. His academic journey continued at Cold Spring Harbor Laboratory, where he earned his PhD in Genomics in 2010. This rigorous training equipped him with the skills to tackle theories and applications at the frontier of genetic research.

    Throughout his career, Dr. Erlich has authored over 40 peer-reviewed scientific studies, highlighting his dedication to advancing knowledge in his field. His work has been published in prestigious journals such as Science, Nature Genetics, Nature Methods, and the American Journal of Human Genetics (AJHG), where he is recognized as a senior author on multiple papers. His research interests have consistently focused on computational human genetics, leading to significant contributions to the understanding of genetic variations and their implications.

    In addition to his research contributions, Dr. Erlich holds five patents, reflecting his innovative approach to solving complex problems in genomics. His experience spans both B2C (business-to-consumer) and B2B (business-to-business) applications within the genomics sector, showcasing his versatility and broad understanding of market needs.

    Achievements

    Dr. Yaniv Erlich has received several prestigious awards and recognitions throughout his career, underlining his status as a leader in the field. Some of his noteworthy accolades include:

    • DARPA’s Young Faculty Award (2017): This award is presented to early-career researchers who have shown exceptional potential in their field, emphasizing Dr. Erlich’s impact on the future of computational genetics.
    • Burroughs Wellcome Career Award (2013): This award highlights significant contributions to biomedical research, showcasing Dr. Erlich's commitment to advancing genomic studies.
    • Harold M. Weintraub Award (2010): Recognizing outstanding young scientists, this honor further reflects Dr. Erlich's early promise in his scientific endeavors.
    • IEEE/ACM-CS HPC Award (2008): This recognition emphasizes his contributions to high-performance computing in computational biology.
    • Tomorrow’s PIs - Genome Technology (2010): This selection as part of Tomorrow’s PIs acknowledges emerging leaders in genomic technology.

    Dr. Erlich is also a recognized speaker, having taken the stage at TEDMED in 2018. His presentation on genomic technology and its implications for healthcare further cements his reputation as an engaging communicator and leader in the field.

    In summary, Prof. Yaniv Erlich’s impressive educational background, robust career history, and numerous accolades highlight his expert status in computational human genetics. As he continues to lead at Eleven Therapeutics, Dr. Erlich remains at the forefront of genomic research and its applications, driving innovation and paving the way for future breakthroughs in the field of biotechnology.

    Related Questions

    How did Prof. Yaniv Erlich develop his expertise in computational human genetics?
    What notable contributions has Prof. Yaniv Erlich made to the field of bioinformatics during his time at Columbia University?
    In what ways does Prof. Yaniv Erlich's experience as an advisor benefit companies in the genomics sector?
    What are the implications of Prof. Yaniv Erlich's research published in high-impact journals for the future of personalized medicine?
    How has Prof. Yaniv Erlich integrated his academic background with his roles in the biotechnology industry to drive innovation?
    Yaniv Erlich
    Add to my network

    Location

    Israel